Jpmorgan Chase & CO Assertio Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,268 shares of ASRT stock, worth $2,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,268
Previous 3,906
16.33%
Holding current value
$2,745
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ASRT
# of Institutions
85Shares Held
26.6MCall Options Held
449KPut Options Held
60K-
Nantahala Capital Management, LLC New Canaan, CT8.81MShares$7.4 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.68 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.82MShares$2.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.16 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$857,9610.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $40.5M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...